InsiderTrades.com logo

RNAC Insider Trading

Insider Ownership Percentage: 60.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $247,337.42

Cartesian Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cartesian Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cartesian Therapeutics Share Price & Price History

Current Price: $6.90
Price Change: ▲ Price Increase of +0.25 (3.76%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for RNAC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cartesian Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/6/2025Blaine DavisCFOSell4,028$16.83$67,791.2494,811View SEC Filing Icon  
1/6/2025Metin KurtogluCTOSell2,458$16.83$41,368.1462,258View SEC Filing Icon  
1/6/2025Miloš MiljkovićInsiderSell948$16.83$15,954.8435,393View SEC Filing Icon  
1/3/2025Blaine DavisCFOSell3,961$16.72$66,227.9298,839View SEC Filing Icon  
1/3/2025Metin KurtogluCTOSell2,417$16.72$40,412.2464,716View SEC Filing Icon  
1/3/2025Miloš MiljkovićInsiderSell932$16.72$15,583.0436,341View SEC Filing Icon  
11/21/2024Metin KurtogluCTOSell32,789$16.67$546,592.6351,033View SEC Filing Icon  
11/18/2024Metin KurtogluCTOSell34,400$18.39$632,616.0051,033View SEC Filing Icon  
11/14/2024Metin KurtogluCTOSell25,900$16.44$425,796.0051,033View SEC Filing Icon  
11/14/2024Miloš MiljkovićInsiderSell35,000$16.13$564,550.0018,273View SEC Filing Icon  
10/4/2024Timothy A. SpringerDirectorBuy80,301$22.58$1,813,196.588,023,766View SEC Filing Icon  
10/2/2024Timothy A. SpringerDirectorBuy5,514$17.38$95,833.327,823,559View SEC Filing Icon  
8/12/2024Timothy A. SpringerDirectorBuy8,016$12.72$101,963.5211,509View SEC Filing Icon  
3/18/2024Timothy A. SpringerDirectorBuy634$18.00$11,412.001,035,780View SEC Filing Icon  
3/14/2024Timothy A. SpringerDirectorBuy21,612$16.20$350,114.401,017,228View SEC Filing Icon  
3/11/2024Timothy A. SpringerDirectorBuy40$19.50$780.003,213View SEC Filing Icon  
3/8/2024Timothy A. SpringerDirectorBuy160$19.80$3,168.003,173View SEC Filing Icon  
2/6/2024Timothy A. SpringerDirectorBuy26$19.50$507.002,933View SEC Filing Icon  
1/17/2024Timothy A. SpringerDirectorBuy26$20.70$538.202,907View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cartesian Therapeutics (NASDAQ:RNAC)

86.95% of Cartesian Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RNAC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cartesian Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.30,001$0.31M0.0%-27.4%0.115%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC25,357$0.26M0.0%N/A0.098%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC25,000$0.26M0.0%N/A0.096%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP86,095$0.88M0.1%+106.9%0.331%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.520,722$5.32M0.0%+4.9%2.003%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC6,924$71K0.0%+64.6%0.027%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE13,933$0.15M0.0%+133.0%0.054%Search for SEC Filing on Google Icon
8/15/2025683 Capital Management LLC219,000$2.28M0.1%+46.0%0.842%Search for SEC Filing on Google Icon
8/14/2025MPM Bioimpact LLC686,007$7.13M1.2%-13.2%2.638%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,056$53K0.0%-16.0%0.019%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP82,630$0.86M0.0%+114.0%0.318%Search for SEC Filing on Google Icon
8/13/2025Virtus Investment Advisers LLC9,183$95K0.0%+12.5%0.035%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.6,080$63K0.0%-96.9%0.023%Search for SEC Filing on Google Icon
8/12/2025Miller Financial Services LLC11,643$0.12M0.2%N/A0.045%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC218,927$2.28M0.0%-2.9%0.844%Search for SEC Filing on Google Icon
7/31/2025AlphaQuest LLC4,207$44K0.0%-41.5%0.016%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.15,775$0.21M0.0%-42.7%0.061%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers13,006$0.17M0.0%+27.5%0.050%Search for SEC Filing on Google Icon
5/23/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.170%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.15,775$0.21M0.0%-42.7%0.061%Search for SEC Filing on Google Icon
5/16/2025683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%Search for SEC Filing on Google Icon
5/15/2025MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%Search for SEC Filing on Google Icon
5/15/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%Search for SEC Filing on Google Icon
5/14/2025AlphaQuest LLC7,191$95K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/14/2025Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%Search for SEC Filing on Google Icon
5/13/2025Twin Focus Capital Partners LLC15,000$0.20M0.0%+25.0%0.058%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC27,869$0.37M0.0%N/A0.107%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG7,424$98K0.0%+104.1%0.029%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.29,303$0.39M0.0%+9.3%0.113%Search for SEC Filing on Google Icon
4/30/2025Alps Advisors Inc.19,392$0.26M0.0%-5.6%0.075%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp20,937$0.28M0.0%+7.9%0.081%Search for SEC Filing on Google Icon
4/8/2025Rhumbline Advisers13,006$0.17M0.0%+27.5%0.050%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP11,812$0.21M0.0%-8.5%0.046%Search for SEC Filing on Google Icon
2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$0.10M0.0%+44.8%0.023%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE11,690$0.21M0.0%+54.4%0.046%Search for SEC Filing on Google Icon
2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC6,667$0.12M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC19,099$0.34M0.0%+64.5%0.075%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC13,800$0.25M0.0%N/A0.054%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%Search for SEC Filing on Google Icon
2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.26,803$0.48M0.0%+40.7%0.105%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp19,407$0.35M0.0%+28.5%0.076%Search for SEC Filing on Google Icon
1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers10,201$0.18M0.0%+10.0%0.040%Search for SEC Filing on Google Icon
1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC11,611$0.19M0.0%+208.6%0.046%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC11,611$0.19M0.0%+208.6%0.046%Search for SEC Filing on Google Icon
11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC52,193$0.84M0.1%-78.5%0.205%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%Search for SEC Filing on Google Icon
11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219%Search for SEC Filing on Google Icon
10/23/2024Lake Street Advisors Group LLC15,822$0.26M0.0%-50.0%0.074%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC13,010$0.35M0.0%N/A0.061%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC13,010$0.35M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP30,038$0.81M0.0%N/A0.140%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC17,052$0.46M0.0%-96.9%0.096%Search for SEC Filing on Google Icon
8/6/2024Lake Street Advisors Group LLC31,644$0.86M0.0%N/A0.178%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers8,487$0.23M0.0%-93.5%0.048%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp19,916$0.54M0.0%-93.7%0.112%Search for SEC Filing on Google Icon
7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC47,134$31K0.0%N/A0.883%Search for SEC Filing on Google Icon
5/3/2024Delphi Financial Group Inc.660,852$0.43M0.3%N/A12.261%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets59,125$38K0.0%N/A1.097%Search for SEC Filing on Google Icon
4/23/2024Hall Laurie J Trustee52,775$34K0.0%N/A0.979%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cartesian Therapeutics logo
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland.
Read More on Cartesian Therapeutics

Today's Range

Now: $6.90
Low: $6.53
High: $7.00

50 Day Range

MA: $8.43
Low: $6.65
High: $10.34

52 Week Range

Now: $6.90
Low: $5.98
High: $26.50

Volume

364,771 shs

Average Volume

129,291 shs

Market Capitalization

$179.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Cartesian Therapeutics?

Cartesian Therapeutics' top insider shareholders include:
  1. Timothy A Springer (Director)
  2. Blaine Davis (CFO)
  3. Metin Kurtoglu (CTO)
  4. Milos Miljkovic (Insider)
Learn More about top insider investors at Cartesian Therapeutics.

Who are the major institutional investors of Cartesian Therapeutics?

Cartesian Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 2.00%
  2. GSA Capital Partners LLP — 0.33%
  3. Jacobs Levy Equity Management Inc. — 0.12%
  4. Millennium Management LLC — 0.10%
  5. Bridgeway Capital Management LLC — 0.10%
  6. Susquehanna International Group LLP — 0.00%
Learn More about top institutional investors of Cartesian Therapeutics stock.

Which major investors are selling Cartesian Therapeutics stock?

Within the previous quarter, RNAC stock was sold by these institutional investors:
  1. Jacobs Levy Equity Management Inc.
During the last year, company insiders that have sold Cartesian Therapeutics company stock include:
  1. Timothy A Springer (Director)
  2. Blaine Davis (CFO)
  3. Metin Kurtoglu (CTO)
Learn More investors selling Cartesian Therapeutics stock.

Which major investors are buying Cartesian Therapeutics stock?

Within the last quarter, RNAC stock was acquired by institutional investors including:
  1. GSA Capital Partners LLP
  2. Millennium Management LLC
  3. Bridgeway Capital Management LLC
  4. Vanguard Group Inc.
  5. Susquehanna International Group LLP
  6. AlphaQuest LLC